{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:14:06Z","timestamp":1783566846575,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300179"],"award-info":[{"award-number":["82300179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012228"],"award-info":[{"award-number":["2024A1515012228"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A04J2105"],"award-info":[{"award-number":["2023A04J2105"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00827-y","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:03:43Z","timestamp":1778951023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated NDUFAF2 expression correlates with poor prognosis and drives metabolic dependency in hepatocellular carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Peiting","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"827_CR1","unstructured":"Cancer Today. 2022:2022\u2013185."},{"key":"827_CR2","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/cncr.35423","volume":"130","author":"M Makarem","year":"2024","unstructured":"Makarem M, Nne J. Top advances of the year: Targeted therapy for lung cancer. Cancer. 2024;130:3239\u201350.","journal-title":"Cancer"},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s40265-020-01411-y","volume":"80","author":"ME Tesch","year":"2020","unstructured":"Tesch ME, Gelmon KA. Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars. Drugs. 2020;80:1811\u201330.","journal-title":"Drugs"},{"key":"827_CR4","unstructured":"Treatment by Cancer Type. 1."},{"key":"827_CR5","first-page":"e18761429358008","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu W, Liao S, Hu Y, Huang Y, Zhou J. Upregulation of miR-3130-5p Enhances Hepatocellular Carcinoma Growth by Suppressing Ferredoxin 1: miR-3130-5p Enhances HCC Growth via Inhibiting FDX1. Curr Mol Pharmacol. 2024;17:e18761429358008.","journal-title":"Curr Mol Pharmacol"},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","volume":"26","author":"IP Gudivada","year":"2025","unstructured":"Gudivada IP, Amajala KC. Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. Curr Genomics. 2025;26:48\u201380.","journal-title":"Curr Genomics"},{"key":"827_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/0113892029313473240919105819","volume":"26","author":"X He","year":"2025","unstructured":"He X, Ma J, Yan X, Yang X, Wang P, Zhang L, Li N, Shi Z. CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer. Curr Genomics. 2025;26:225\u201343.","journal-title":"Curr Genomics"},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"Mu R, Chang M, Feng C, Cui Y, Li T, Liu C, Wang Y, Guo X. Analysis of the Expression of PRDX6 in Patients with Hepatocellular Carcinoma and its Effect on the Phenotype of Hepatocellular Carcinoma Cells. Curr Genomics. 2024;25:2\u201311.","journal-title":"Curr Genomics"},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.tranon.2024.101965","volume":"45","author":"Z Li","year":"2024","unstructured":"Li Z, Lu W, Yin F, Huang A. YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro study. Transl Oncol. 2024;45:101965.","journal-title":"Transl Oncol"},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell. 2008;13:472\u201382.","journal-title":"Cancer Cell"},{"key":"827_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, Zhang C, Liu D, Zheng M, Gao J. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9:124.","journal-title":"Signal Transduct Target Ther"},{"key":"827_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1089\/ars.2013.5255","volume":"19","author":"Z Cheng","year":"2013","unstructured":"Cheng Z, Ristow M. Mitochondria and metabolic homeostasis. Antioxid Redox Signal. 2013;19:240\u20132.","journal-title":"Antioxid Redox Signal"},{"key":"827_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-biochem-070511-103700","volume":"82","author":"J Hirst","year":"2013","unstructured":"Hirst J. Mitochondrial complex I. Annu Rev Biochem. 2013;82:551\u201375.","journal-title":"Annu Rev Biochem"},{"key":"827_CR14","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1111\/febs.16218","volume":"289","author":"M Sollazzo","year":"2022","unstructured":"Sollazzo M, De Luise M, Lemma S, Bressi L, Iorio M, Miglietta S, Milioni S, Kurelac I, Iommarini L, Gasparre G, Porcelli AM. Respiratory Complex I dysfunction in cancer: from a maze of cellular adaptive responses to potential therapeutic strategies. FEBS J. 2022;289:8003\u201319.","journal-title":"FEBS J"},{"key":"827_CR15","doi-asserted-by":"publisher","first-page":"eads5466","DOI":"10.1126\/sciadv.ads5466","volume":"10","author":"CR Reczek","year":"2024","unstructured":"Reczek CR, Chakrabarty RP, D\u2019Alessandro KB, Sebo ZL, Grant RA, Gao P, Budinger GR, Chandel NS. Metformin targets mitochondrial complex I to lower blood glucose levels. Sci Adv. 2024;10:eads5466.","journal-title":"Sci Adv"},{"key":"827_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ymgme.2007.11.013","volume":"94","author":"F Barghuti","year":"2008","unstructured":"Barghuti F, Elian K, Gomori JM, Shaag A, Edvardson S, Saada A, Elpeleg O. The unique neuroradiology of complex I deficiency due to NDUFA12L defect. Mol Genet Metab. 2008;94:78\u201382.","journal-title":"Mol Genet Metab"},{"key":"827_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0030-1255062","volume":"41","author":"M Herzer","year":"2010","unstructured":"Herzer M, Koch J, Prokisch H, Rodenburg R, Rauscher C, Radauer W, Forstner R, Pilz P, Rolinski B, Freisinger P, Mayr JA, Sperl W. Leigh disease with brainstem involvement in complex I deficiency due to assembly factor NDUFAF2 defect. Neuropediatrics. 2010;41:30\u20134.","journal-title":"Neuropediatrics"},{"key":"827_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/jmg.2011.088856","volume":"48","author":"E Ostergaard","year":"2011","unstructured":"Ostergaard E, Rodenburg RJ, van den Brand M, Thomsen LL, Duno M, Batbayli M, Wibrand F, Nijtmans L. Respiratory chain complex I deficiency due to NDUFA12 mutations as a new cause of Leigh syndrome. J Med Genet. 2011;48:737\u201340.","journal-title":"J Med Genet"},{"key":"827_CR19","doi-asserted-by":"crossref","unstructured":"Zou K, Gao P, Xu X, Zhang W, Zeng Z. Upregulation of NDUFAF2 in lung adenocarcinoma is a novel independent prognostic biomarker. Comput Math Methods Med. 2023;2023:2912968.","DOI":"10.1155\/2023\/2912968"},{"key":"827_CR20","doi-asserted-by":"publisher","first-page":"19977","DOI":"10.1074\/jbc.M501231200","volume":"280","author":"M Tsuneoka","year":"2005","unstructured":"Tsuneoka M, Teye K, Arima N, Soejima M, Otera H, Ohashi K, Koga Y, Fujita H, Shirouzu K, Kimura H, Koda Y. A novel Myc-target gene, mimitin, that is involved in cell proliferation of esophageal squamous cell carcinoma. J Biol Chem. 2005;280:19977\u201385.","journal-title":"J Biol Chem"},{"key":"827_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nbd.2013.05.007","volume":"58","author":"JS Schlehe","year":"2013","unstructured":"Schlehe JS, Journel MS, Taylor KP, Amodeo KD, LaVoie MJ. The mitochondrial disease associated protein Ndufaf2 is dispensable for Complex-1 assembly but critical for the regulation of oxidative stress. Neurobiol Dis. 2013;58:57\u201367.","journal-title":"Neurobiol Dis"},{"key":"827_CR22","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/cas.12710","volume":"106","author":"M Chen","year":"2015","unstructured":"Chen M, Huang H, He H, Ying W, Liu X, Dai Z, Yin J, Mao N, Qian X, Pan L. Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines. Cancer Sci. 2015;106:1075\u201383.","journal-title":"Cancer Sci"},{"key":"827_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-024-05112-y","volume":"22","author":"Z Li","year":"2024","unstructured":"Li Z, Lu W, Yin F, Zeng P, Li H, Huang A. Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma. J Transl Med. 2024;22:340.","journal-title":"J Transl Med"},{"key":"827_CR24","doi-asserted-by":"publisher","first-page":"782065","DOI":"10.3389\/fonc.2021.782065","volume":"11","author":"A Huang","year":"2021","unstructured":"Huang A, Zeng P, Li Y, Lu W, Lai Y. LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K\/Akt Signaling Pathway. Front Oncol. 2021;11:782065.","journal-title":"Front Oncol"},{"key":"827_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3892\/ijo.2016.3774","volume":"50","author":"K Liu","year":"2017","unstructured":"Liu K, Tang Z, Huang A, Chen P, Liu P, Yang J, Lu W, Liao J, Sun Y, Wen S, Hu Y, Huang P. Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression. Int J Oncol. 2017;50:252\u201362.","journal-title":"Int J Oncol"},{"key":"827_CR26","first-page":"555","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria Cancer Cell. 2016;166:555\u201366.","journal-title":"Mitochondria Cancer Cell"},{"key":"827_CR27","first-page":"667","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong WX, Rabinowitz JD, White E. Mitochondria Cancer Mol Cell. 2016;61:667\u201376.","journal-title":"Mitochondria Cancer Mol Cell"},{"key":"827_CR28","doi-asserted-by":"publisher","first-page":"216705","DOI":"10.1016\/j.canlet.2024.216705","volume":"587","author":"C Uslu","year":"2024","unstructured":"Uslu C, Kapan E, Lyakhovich A. Cancer resistance and metastasis are maintained through oxidative phosphorylation. Cancer Lett. 2024;587:216705.","journal-title":"Cancer Lett"},{"key":"827_CR29","doi-asserted-by":"crossref","unstructured":"Kenny TC, Birsoy K. Mitochondria and cancer. Cold Spring Harb Perspect Med. 2024;14.","DOI":"10.1101\/cshperspect.a041534"},{"key":"827_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"827_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"WARBURG O","year":"1956","unstructured":"WARBURG O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"827_CR32","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative Phosphorylation as an Emerging Target in Cancer Therapy. Clin Cancer Res. 2018;24:2482\u201390.","journal-title":"Clin Cancer Res"},{"key":"827_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, Kantarjian HM, Ravandi F, Collins ME, Francesco M, Dumbrava EE, Fu S, Gao S, Gay JP, Gera S, Han J, Hong DS, Jabbour EJ, Ju Z, Karp DD, Lodi A, Molina JR, Baran N, Naing A, Ohanian M, Pant S, Pemmaraju N, Bose P, Piha-Paul SA, Rodon J, Salguero C, Sasaki K, Singh AK, Subbiah V, Tsimberidou AM, Xu QA, Yilmaz M, Zhang Q, Li Y, Bristow CA, Bhattacharjee MB, Tiziani S, Heffernan TP, Vellano CP, Jones P, Heijnen CJ, Kavelaars A, Marszalek JR, Konopleva M. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023;29:115\u201326.","journal-title":"Nat Med"},{"key":"827_CR34","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, Chang E, Ciurea S, Cross JB, Czako B, Deem A, Daver N, de Groot JF, Dong JW, Feng N, Gao G, Gay J, Do MG, Greer J, Giuliani V, Han J, Han L, Henry VK, Hirst J, Huang S, Jiang Y, Kang Z, Khor T, Konoplev S, Lin YH, Liu G, Lodi A, Lofton T, Ma H, Mahendra M, Matre P, Mullinax R, Peoples M, Petrocchi A, Rodriguez-Canale J, Serreli R, Shi T, Smith M, Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q, Muller F, DePinho RA, Toniatti C, Draetta GF, Heffernan TP, Konopleva M, Jones P. Di Francesco ME and Marszalek JR. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018;24:1036\u201346.","journal-title":"Nat Med"},{"key":"827_CR35","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","volume":"24","author":"DY Lissanu","year":"2018","unstructured":"Lissanu DY, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran C, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA. Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med. 2018;24:1047\u201357.","journal-title":"Nat Med"},{"key":"827_CR36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1158\/1078-0432.CCR-24-3296","volume":"31","author":"A Beerkens","year":"2025","unstructured":"Beerkens A, Heskamp S, Reinema FV, Adema GJ, Span PN, Bussink J. Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment Efficacy. Clin Cancer Res. 2025;31:1186\u201393.","journal-title":"Clin Cancer Res"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00827-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:34:06Z","timestamp":1783564446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00827-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00827-y","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}